Stephanie Bouchard
As the healthcare industry works to attain the so-called Triple Aim of affordability, access and quality, doctors will be key said Christine Cassel, MD, Thursday during a leadership conference in Maine.
A new study reveals that financial risk plays a role in underuse of hospice care in the United States.
The Department of Justice announced Tuesday that False Claims Act recoveries in 2012 set records, including for healthcare recoveries, which topped $3 billion.
The American Academy of Nurse Practitioners and the American College of Nurse Practitioners will consolidate effective Jan. 1. 2013, the two membership organizations announced last month.
AHRQ review finds lack of evidence to determine cost effectiveness of home versus institutional care
The message that home- and community-based care is more cost effective than institutional care has been touted by federal and local governments and those within the healthcare community, but a new comparative effectiveness review of long-term care of older adults receiving home- and community-based services versus care in institutions concludes that there is not enough evidence in the literature to determine cost effectiveness.
The 2012 HomeCare Elite, a list of the top performing home health agencies in the United States, was announced Tuesday.
A South Carolina-based hospice company has agreed to settle false claims allegations for $1.287 million, the Department of Justice announced last week.
Most folks think of care services when they think of hospices, but one enterprising hospice in Las Vegas is expanding its business model by venturing into mobile technology.
An organizational culture study surveying physicians, and a companion study of hospital administrators, found a disconnect between doctors and administrators on issues of cultural fit and organizational performance.
Like all major mature markets, the pharmaceutical industry is facing big changes that are playing havoc with productivity and profits. A new analysis released Thursday aims to help pharma usher in a new era of prosperity.